You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Bay 73-4506

Showing 1 - 25 of 1,177
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Pancreatic Adenocarcinoma Trial in Cleveland (Regorafenib, Gemcitabine Hydrochloride)

Terminated
Has Results
  • Metastatic Pancreatic Adenocarcinoma
  • Cleveland, Ohio
    Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
Jun 1, 2022

Learn More About Order of Different Treatments and Their Effects

Not yet recruiting
  • Metastatic Colorectal Cancer
  • Regorafenib (Stivarga, BAY73-4506)
  • (no location specified)
Nov 13, 2023

Learn More About Long-Term Responses to Treatment With

Not yet recruiting
  • Metastatic Colorectal Cancer
  • Regorafenib (Stivarga, BAY73-4506)
  • Whippany, New Jersey
    Bayer
Sep 1, 2023

Gastrointestinal Stromal Tumors Trial in Miami (Sunitinib, Regorafenib)

Recruiting
  • Gastrointestinal Stromal Tumors
  • Miami, Florida
    University of Miami
Jan 3, 2023

Pediatric Oncology Trial in Worldwide (Regorafenib (BAY73-4506), Vincristine (Cellcristin®), Irinotecan (Irinotecan Cell

Active, not recruiting
  • Pediatric Oncology
  • Regorafenib (BAY73-4506)
  • +2 more
  • Lyon, France
  • +11 more
Jan 16, 2023

MSI-H Colorectal Cancer Trial in Pittsburgh (Regorafenib, Pembrolizumab)

Not yet recruiting
  • MSI-H Colorectal Cancer
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Aug 17, 2023

Colorectal Liver Metastases Trial in Beijing (Tislelizumab, Regorafenib, HAIC)

Recruiting
  • Colorectal Liver Metastases
  • Beijing, Beijing, China
  • +1 more
May 25, 2023

Called ROCURS, to Learn About COVID-19 Related Outcomes in

Active, not recruiting
  • Malignant Solid Tumors
  • +2 more
  • Whippany, New Jersey
    Bayer
Feb 2, 2023

Colorectal Cancer, Colon Cancer, Rectum Cancer Trial in Houston (Regorafenib, XmAb20717)

Not yet recruiting
  • Colorectal Cancer
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
May 31, 2023

Regorafenib Post-marketing Surveillance in Japan

Completed
  • Gastrointestinal Stromal Tumors
  • Regorafenib (Stivarga, BAY73-4506)
  • Multiple Locations, Japan
    (unnamed)
Mar 21, 2022

Called STAR-T to Learn More About Sequential Treatment With

Not yet recruiting
  • Metastatic Colorectal Cancer (mCRC)
  • Regorafenib (BAY73-4506, Stivarga®)
  • +2 more
  • Whippany, New Jersey
    Many locations
Apr 21, 2023

Metastatic Solid Malignancies, Locally Advanced Solid Malignancies Trial in Edmonton (Regorafenib)

Withdrawn
  • Metastatic Solid Malignancies
  • Locally Advanced Solid Malignancies
  • Edmonton, Alberta, Canada
    Cross Cancer Institute
Jun 18, 2021

Hepatocellular Carcinoma (HCC) Trial in Taiwan (Chidamide, Regorafenib)

Recruiting
  • Hepatocellular Carcinoma (HCC)
  • Kaohsiung, Taiwan
  • +4 more
Mar 14, 2023

Adult Angiosarcoma, Recurrent Adult Soft Tissue Sarcoma, Stage III Adult Soft Tissue Sarcoma Trial in United States

Completed
Has Results
  • Adult Angiosarcoma
  • +3 more
  • Santa Monica, California
  • +6 more
Mar 29, 2022

Colorectal Cancer, Colorectal Cancer Metastatic Trial in United States (Pembrolizumab, Regorafenib)

Active, not recruiting
  • Colorectal Cancer
  • Colorectal Cancer Metastatic
  • Duarte, California
  • +3 more
Aug 5, 2022

Gastrinoma, Glucagonoma, Insulinoma Trial in United States (regorafenib, laboratory biomarker analysis)

Completed
Has Results
  • Gastrinoma
  • +8 more
  • Scottsdale, Arizona
  • +4 more
Nov 15, 2021

Hepatocellular Carcinoma Trial in Hong Kong (Durvalumab, Sorafenib, Lenvatinib)

Recruiting
  • Hepatocellular Carcinoma
  • Hong Kong, Hong Kong SAR, Hong Kong
    Humanity & Health Research Centre
Mar 16, 2022

Metastatic Colorectal Cancer Trial in India (Regorafenib (Stivarga, BAY73-4506))

Active, not recruiting
  • Metastatic Colorectal Cancer
  • Regorafenib (Stivarga, BAY73-4506)
  • Hyderabad, Andhra Pradesh, India
  • +12 more
Jan 13, 2023

Advanced Colorectal Adenocarcinoma, Advanced Microsatellite Stable Colorectal Carcinoma, Metastatic Colorectal Adenocarcinoma

Not yet recruiting
  • Advanced Colorectal Adenocarcinoma
  • +5 more
  • Balstilimab
  • +4 more
  • Duarte, California
    City of Hope Medical Center
Jan 3, 2023

Rectal Cancer Trial in Switzerland (drug, radiation, procedure)

Terminated
  • Rectal Cancer
  • Basel, Switzerland
  • +6 more
Jan 14, 2022

Carcinoma, Hepatocellular Trial in Germany, United States (Regorafenib(Stivarga, BAY73-4506), Pembrolizumab)

Active, not recruiting
  • Carcinoma, Hepatocellular
  • Los Angeles, California
  • +6 more
Aug 15, 2022

Carcinoma, Renal Cell Trial in Worldwide (Regorafenib (Stivarga, BAY73-4506))

Completed
Has Results
  • Carcinoma, Renal Cell
  • Regorafenib (Stivarga, BAY73-4506)
  • Los Angeles, California
  • +17 more
Jan 27, 2021

Cancer of the Bile Duct Trial in Tampa, Chapel Hill, Richmond (Regorafenib)

Completed
Has Results
  • Cancer of the Bile Duct
  • Tampa, Florida
  • +2 more
Sep 20, 2021

Stage IB Hepatocellular Carcinoma AJCC v8, Stage II Hepatocellular Carcinoma AJCC v8, Stage IIIA Hepatocellular Carcinoma AJCC

Not yet recruiting
  • Stage IB Hepatocellular Carcinoma AJCC v8
  • +2 more
  • Gainesville, Florida
  • +3 more
Jun 15, 2022

Hepatocellular Carcinoma, Regorafenib, PD-1 Inhibitor Trial in Beijing (Regorafenib, PD-1 inhibitor)

Recruiting
  • Hepatocellular Carcinoma
  • +2 more
  • Beijing, Beijing, China
    Hai-Tao Zhao
Sep 15, 2021